SCHEMBL21664045

SCHEMBL21664045

C[C@@]12CSC(=N1)c1cc(cs1)C[C@@H](C(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c3ccccc13)NC(=O)[C@@H](CC1CCCCC1)NC(=O)C1CCCN1C2=O

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSLP Q969D9 4/20 0.43
MC5R P33032 8/20 0.42
MC3R P41968 8/20 0.42
MC4R P32245 6/20 0.42
KLKB1 P03952 4/20 0.42
MC1R Q01726 3/20 0.42
F12 P00748 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21664048 1.00 TSLP (0.43) TSLPMC5RMC3RMC4RKLKB1
SCHEMBL21664096 0.81 MC3R (0.49) TSLPMC5RMC3RMC4RKLKB1
SCHEMBL21688855 0.79 MC3R (0.47) TSLPMC5RMC3RMC4RMC1R
SCHEMBL21664208 0.78 KLKB1 (0.46) TSLPMC5RMC3RMC4RKLKB1
SCHEMBL21664207 0.78 TSLP (0.44) TSLPMC5RMC3RMC4RKLKB1
SCHEMBL21664216 0.78 MC3R (0.52) TSLPMC5RMC3RMC4RKLKB1
SCHEMBL21664060 0.77 TSLP (0.53) TSLPMC5RMC3RMC4RKLKB1
SCHEMBL21664068 0.77 TSLP (0.56) TSLPMC5RMC3RKLKB1F12
SCHEMBL21664161 0.76 MMP2 (0.49) TSLPMC5RMC3RMC4RKLKB1
SCHEMBL12706706 0.74 OPRM1 (0.61) TSLPMC5RMC3RMC4RMC1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11319347-B2 Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound FUJIFILM CORPORATION (JP) 2022-05-03 US disclosed
US-20200040039-A1 PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND FUJIFILM CORPORATION (JP) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200040039-A1 PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND VIP, NPPA, NGLY1 TSLP 1109/4885MC5R 1153/4885MC3R 1620/4885
US-11319347-B2 Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound VIP, NPPA, NGLY1 TSLP 1109/4885MC5R 1153/4885MC3R 1620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.